Step by step

Our main challenge is RESEARCH (dedicating 25% of annual revenue to the research department).

Clinical trials in the area of dermatology enter into their ﬁnal stages after years of studies.

The ﬁnal stage of clinical research is also reached in the studies being carried out on patients with pharyngitis, for the forthcoming launch of Faringoforte.

New studies with Nasodren® widen its range of possible indications for treating important respiratory diseases and other highly prevalent pathologies.

New clinical trials have been conducted to evaluate the efficacy and safety of this product in monotherapy or adjunctive therapy with antibiotics in patients diagnosed of moderate to severe Acute Rhinosinusitis; and in the postoperative evolution of patients with nasal polyps undergoing endoscopic sinus surgery.

Some of them will be presented in next Rhinology World congress in Philadelphia, USA.